It’s no secret that many in the diabetes community use medications in ways that aren’t FDA-approved and deviate from what the product labeling says, otherwise known as “ off-label use.” In particular, ...

A large percentage of patients with type 2 diabetes enrolled in Medicaid have restricted access to sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor ...

This article was reviewed by Darragh O’Carroll, MD. Key takeaways: Some medications FDA-approved for type 2 diabetes can promote weight loss. Diabetes medications for weight loss include Ozmepic®, ...

Physicians have hesitated to prescribe GLP-1RA medications, such as those with brand names of Ozempic and Victoza, to patients with a history of pancreatitis because it was believed they could ...

The daily struggle of managing type 2 diabetes has consumed the lives of millions of Americans who face constant blood sugar monitoring, medication schedules, and dietary restrictions that can feel ...

A new and increasingly widely used diabetes medication may have additional health benefits for older adults, according to new research which looked at data from more than 300,000 patients who have ...

GLP-1RA (glucagon-like peptide-1 receptor agonist) medications, which are prescribed to treat Type 2 diabetes and to help with weight loss, were found to reduce the number of deaths, amputations and ...

One year of dual antiplatelet therapy with one of two potent P2Y12 inhibitors—ticagrelor or prasugrel—in people with Type 1 or Type 2 diabetes who had received a drug-eluting stent did not offer the ...

These meds are sometimes prescribed off-label for people with overweight or obesity. Most of these diabetes drugs promote weight loss by suppressing appetite and making you feel fuller. You might have ...

You might have heard about medications like Ozempic®, Mounjaro®, and metformin for weight loss. But these drugs are actually diabetes medications that are sometimes prescribed off-label for weight ...